AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
IBRX vs AAPL Fundamental Comparison
| Metric | IBRX | AAPL |
|---|---|---|
| Revenue | $113.3M | $143.8B |
| Net Income | $-351.4M | $42.1B |
| Net Margin | -310.2% | 29.3% |
| ROE | N/A | 47.7% |
| ROA | -70.0% | 11.1% |
| Current Ratio | 5.10x | 0.97x |
| Debt/Equity | N/A | 1.00x |
| EPS | $-0.38 | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IBRX vs AAPL: Frequently Asked Questions
Is IBRX or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. IBRX is rated STRONG SELL (92% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does IBRX compare to AAPL fundamentally?
ImmunityBio, Inc. has ROE of N/A vs Apple Inc.'s 47.7%. Net margins are -310.2% vs 29.3% respectively.
Which stock pays higher dividends, IBRX or AAPL?
IBRX has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IBRX or AAPL for long term?
For long-term investing, consider that IBRX has STRONG SELL rating with 92% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IBRX vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IBRX vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.